The global non-insulin peptide drugs market is on the cusp of transformative growth, valued at USD 61.5 billion in 2025 and projected to expand to USD 184.2 billion by 2035, according to the latest analysis from Future Market Insights (FMI). This represents a robust compound annual growth rate (CAGR) of 11.6%, with an absolute growth of USD 122.7 billion over the forecast period...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek